Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Cantor Fitzgerald
Baxter
Cipla
Fish and Richardson
McKinsey
McKesson
Express Scripts
Chinese Patent Office

Generated: July 17, 2018

DrugPatentWatch Database Preview

Aqua Pharms Company Profile

« Back to Dashboard

Summary for Aqua Pharms
International Patents:146
US Patents:12
Tradenames:11
Ingredients:9
NDAs:11

Drugs and US Patents for Aqua Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aqua Pharms VERDESO desonide AEROSOL, FOAM;TOPICAL 021978-001 Sep 19, 2006 RX Yes Yes 8,962,000 ➤ Sign Up Y ➤ Sign Up
Aqua Pharms CORDRAN SP flurandrenolide CREAM;TOPICAL 012806-002 Approved Prior to Jan 1, 1982 AT RX Yes Yes ➤ Sign Up ➤ Sign Up
Aqua Pharms CORDRAN flurandrenolide OINTMENT;TOPICAL 012806-001 Approved Prior to Jan 1, 1982 AT RX Yes Yes ➤ Sign Up ➤ Sign Up
Aqua Pharms MONODOX doxycycline CAPSULE;ORAL 050641-002 Feb 10, 1992 AB RX Yes No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Aqua Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aqua Pharms SOLAGE mequinol; tretinoin SOLUTION;TOPICAL 020922-001 Dec 10, 1999 5,194,247 ➤ Sign Up
Aqua Pharms Llc VELTIN clindamycin phosphate; tretinoin GEL;TOPICAL 050803-001 Jul 16, 2010 5,690,923 ➤ Sign Up
Aqua Pharms SOLAGE mequinol; tretinoin SOLUTION;TOPICAL 020922-001 Dec 10, 1999 5,470,567 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for Aqua Pharms

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,263,580 Vitamin formulation ➤ Sign Up
6,238,683 Anhydrous topical skin preparations ➤ Sign Up
8,629,128 Vitamin formulation ➤ Sign Up
8,298,515 Vitamin formulation ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Supplementary Protection Certificates for Aqua Pharms Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
00617 Netherlands ➤ Sign Up PRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322
C/GB07/061 United Kingdom ➤ Sign Up PRODUCT NAME: RETAPAMULIN OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT; REGISTERED: UK EU/1/07/390/001 20070524; UK EU/1/07/390/002 20070524; UK EU/1/07/390/003 20070524; UK EU/1/07/390/004 20070524
2007 00052 Denmark ➤ Sign Up
2013025,C1304992 Lithuania ➤ Sign Up PRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Covington
McKinsey
Healthtrust
Accenture
Chubb
Queensland Health
Express Scripts
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.